JEFFREY BARONE: Open Payments
NPI 1851620231 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 69 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $351 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $192 |
| Amgen Inc. | 15 | $170 |
| Exact Sciences Corporation | 11 | $170 |
| ABBVIE INC. | 6 | $121 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Eisai Inc. | 2 | $66 |
| Novo Nordisk Inc | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Astellas Pharma US Inc | 2 | $40 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
Products named: Cologuard Collection Kit, OTEZLA, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, Leqembi, CAPVAXIVE, Veozah.
Industry payments across AZ — which companies pay providers there.
